Top Clinical Trials companies in Norway by EBIT Margin

This ranking features the top 4 Clinical Trials companies in Norway ranked by EBIT Margin, averaging a EBIT Margin of -13,660.81%, for February 07, 2025.

Norway

Clinical Trials
EBIT Margin
#
Name
EBIT Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
GENT.OL

Gentian Diagnostics ASA

1

GENT.OL
-6.97%
Dec. 31, 2023 USD 4.31 4.92%

Norway
2
LIFE.OL

Lifecare AS

2

LIFE.OL
-270.12%
Dec. 31, 2023 USD 1.13 -2.55%

Norway
3
PCIB.OL

PCI Biotech Holding ASA

3

PCIB.OL
-743.85%
Dec. 31, 2023 USD 0.11 -0.62%

Norway
4
BGBIO.OL

BerGenBio ASA

4

BGBIO.OL
-53,622.32%
Dec. 31, 2023 USD 0.73 3.02%

Norway
Frequently Asked Questions
  • Which Clinical Trials company in Norway has the highest EBIT Margin ?

    The Clinical Trials company in Norway with the highest EBIT Margin is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at -6.97%.

  • Which Clinical Trials company in Norway has the lowest EBIT Margin ?

    The Clinical Trials company in Norway with the lowest EBIT Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -53,622.32%.

SV Wall Street